Abstract:The use of dexamethasone for eye disease treatment is limited by its low solubility, bioavailability, and rapid elimination when applied topically. The covalent conjugation of dexamethasone with polymeric carriers is a promising strategy to overcome existing drawbacks. In this work, amphiphilic polypeptides capable of self-assembly into nanoparticles were proposed as potential delivery systems for intravitreal delivery. The nanoparticles were prepared and characterized using poly(L-glutamic acid-co-D-phenylalanine) and poly(L-lysine-co-D/L-phenylalanine) as well as poly(L-lysine-co-D/L-phenylalanine) covered with heparin. The critical association concentration for the polypeptides obtained was in the 4.2-9.4 μg/mL range. The hydrodynamic size of the formed nanoparticles was between 90 and 210 nm, and they had an index of polydispersity between 0.08 and 0.27 and an absolute zeta-potential value between 20 and 45 mV. The ability of nanoparticles to migrate in the vitreous humor was examined using intact porcine vitreous. Conjugation of DEX with polypeptides was performed by additional succinylation of DEX and activation of carboxyl groups introduced to react with primary amines in polypeptides. The structures of all intermediate and final compounds were verified by 1H NMR spectroscopy. The amount of conjugated DEX can be varied from 6 to 220 µg/mg of polymer. The hydrodynamic diameter of the nanoparticle-based conjugates was increased to 200-370 nm, depending on the polymer sample and drug loading. The release of DEX from the conjugates due to hydrolysis of the ester bond between DEX and the succinyl moiety was studied both in a buffer medium and a vitreous/buffer mixture (50/50, v/v). As expected, the release in the vitreous medium was faster. However, the release rate could be controlled in the range of 96-192 h by varying the polymer composition. In addition, several mathematical models were used to assess the release profiles and figure out how DEX is released.

Methoxy Poly（ethylene Glycol）-B-poly（ethyl Cyanoacrylate） Copolymer Nanoparticles As Delivery Vehicles for Dexamethasone

Poly(trimethylene Carbonate) and Monomethoxy Poly(ethylene Glycol)-Block-poly(trimethylene Carbonate) Nanoparticles for the Controlled Release of Dexamethasone.

Preparation and characterization of Dexamethasone acetate loaded PEG-PLGA nanoparticles

Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- Caprolactone) Bearing Pendant Hydroxyl Groups As Nanocarriers for Doxorubicin Delivery.

The Preparation of Dexamethasone Acetate Lipid Nanoparticles

Synthesis and characterization of poly(methoxyl ethylene glycol-caprolactone-co-methacrylic acid-co-poly(ethylene glycol) methyl ether methacrylate) pH-sensitive hydrogel for delivery of dexamethasone.

Preparation and in Vivo Pharmacokinetics of Polyethylene Glycol-Modified Nanoparticles Loaded with Dexamethasone Acetate

Methoxy Poly(Ethylene Glycol)-B-Poly(Octadecanoic Anhydride)-B-Methoxy Poly(Ethylene Glycol) Amphiphilic Triblock Copolymer Nanoparticles As Delivery Vehicles for Paclitaxel

A Novel Strategy for Encapsulating Poorly Soluble Drug into Nanostructured Lipid Carriers for Intravenous Administration

Design and characterization of dexamethasone phosphate -loaded microcapsules obtained by a double-emulsion method

Exploring Poly(Ethylene Glycol)-Poly(Trimethylene Carbonate) Nanoparticles as Carriers of Hydrophobic Drugs to Modulate Osteoblastic Activity

Preparation and Characterization of Poly{[Alpha-Maleic Anhydride-Omega-Methoxypoly-Poly(Ethylene Glycol)]-Co-(Ethyl Cyanoacrylate)} Copolymer Nanoparticles

Delivery system for dexamethasone phosphate based on a Zn 2+ -crosslinked polyelectrolyte complex of diethylaminoethyl chitosan and chondroitin sulfate

Synthesis and Characterization of Nanoparticle-Based Dexamethasone-Polypeptide Conjugates as Potential Intravitreal Delivery Systems

Controlled Release of Doxorubicin from Amphiphilic Depsipeptide–pdo–peg-Based Copolymer Nanosized Microspheres

OPTIMIZATION OF PREPARATION OF DEXAMETHASONE ACETATE-LOADED POLY(D,L-LACTIDE) MICROSPHERES BY CENTRAL COMPOSITE DESIGN

Electrophoretic Deposition of Dexamethasone-Loaded Mesoporous Silica Nanoparticles Onto Poly(L-Lactic Acid)/Poly(ε-Caprolactone) Composite Scaffold for Bone Tissue Engineering.

PLA–PCL–PEG–PCL–PLA based micelles for improving the ocular permeability of dexamethasone: development, characterization, and in vitro evaluation

Preparation and in Vitro Characterization of Dexamethasone-Loaded Poly(d,l-Lactic Acid) Microspheres Embedded in Poly(ethylene Glycol)–poly(ɛ-Caprolactone)–poly(ethylene Glycol) Hydrogel for Orthopedic Tissue Engineering

Novel AB4-Type CTBN-b-MPEG PU Micelle-like Amphiphilic Block Copolymer Micelles for Prednisone Drug Release

Synthesis, Characterization and Drug Loading Property of Monomethoxy-Poly(ethylene Glycol)-Poly(ε-caprolactone)-poly(d,l-lactide) (MPEG-PCLA) Copolymers.